SCHEMBL996605

SCHEMBL996605

OC(CCl)C(Cl)OC(CCl)CCl

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL996604 0.69 MAPK1 (0.41)
SCHEMBL14694254 0.69 TDP1 (0.35) TSHR
SCHEMBL9093312 0.67
SCHEMBL21114488 0.65
SCHEMBL29557438 0.65
SCHEMBL965530 0.65
SCHEMBL7169460 0.65
SCHEMBL3908392 0.64
SCHEMBL946153 0.64
SCHEMBL32685228 0.64 TSHR (0.41) ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3004282-B1 ENHANCED OIL RECOVERY METHOD EMPLOYING A BIODEGRADABLE BRINE TOLERANT FOAM-FORMING COMPOSITION DOW GLOBAL TECHNOLOGIES LLC (US) 2017-06-21 EP disclosed
EP-3004282-A1 ENHANCED OIL RECOVERY METHOD EMPLOYING A BIODEGRADABLE BRINE TOLERANT FOAM-FORMING COMPOSITION Dow Global Technologies LLC (US) 2016-04-13 EP disclosed
US-20160083643-A1 ENHANCED OIL RECOVERY METHOD EMPLOYING A BIODEGRADABLE BRINE TOLERANT FOAM-FORMING COMPOSITION DOW GLOBAL TECHNOLOGIES LLC (US) 2016-03-24 US disclosed
EP-2454233-B1 SULFONATE SURFACTANTS AND METHODS FOR THEIR PREPARATION AND USE DOW GLOBAL TECHNOLOGIES LLC (US) 2015-02-25 EP disclosed
WO-2014193730-A1 ENHANCED OIL RECOVERY METHOD EMPLOYING A BIODEGRADABLE BRINE TOLERANT FOAM-FORMING COMPOSITION DOW GLOBAL TECHNOLOGIES LLC (US) 2014-12-04 WO disclosed
US-8304377-B2 Sulfonate surfactants and methods of preparation and use DOW GLOBAL TECHNOLOGIES LLC (US) 2012-11-06 US disclosed
EP-2454233-A2 SULFONATE SURFACTANTS AND METHODS OF PREPARATION AND USE Dow Global Technologies LLC (US) 2012-05-23 EP disclosed
US-20110015111-A1 SULFONATE SURFACTANTS AND METHODS OF PREPARATION AND USE DCOMCO, INC. 2011-01-20 US disclosed
WO-2011008570-A2 SULFONATE SURFACTANTS AND METHODS OF PREPARATION AND USE DOW GLOBAL TECHNOLOGIES, INC. (US) 2011-01-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110015111-A1 SULFONATE SURFACTANTS AND METHODS OF PREPARATION AND USE STS, SRR, SGMS1 ALDH1A1 3530/4885TSHR 289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.